IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v531y2016i7594d10.1038_nature17180.html
   My bibliography  Save this article

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

Author

Listed:
  • Travis K. Warren

    (United States Army Medical Research Institute of Infectious Diseases
    United States Army Medical Research Institute of Infectious Diseases, Therapeutic Development Center)

  • Robert Jordan

    (Gilead Sciences)

  • Michael K. Lo

    (Centers for Disease Control and Prevention)

  • Adrian S. Ray

    (Gilead Sciences)

  • Richard L. Mackman

    (Gilead Sciences)

  • Veronica Soloveva

    (United States Army Medical Research Institute of Infectious Diseases
    United States Army Medical Research Institute of Infectious Diseases, Therapeutic Development Center)

  • Dustin Siegel

    (Gilead Sciences)

  • Michel Perron

    (Gilead Sciences)

  • Roy Bannister

    (Gilead Sciences)

  • Hon C. Hui

    (Gilead Sciences)

  • Nate Larson

    (Gilead Sciences)

  • Robert Strickley

    (Gilead Sciences)

  • Jay Wells

    (United States Army Medical Research Institute of Infectious Diseases)

  • Kelly S. Stuthman

    (United States Army Medical Research Institute of Infectious Diseases)

  • Sean A. Van Tongeren

    (United States Army Medical Research Institute of Infectious Diseases)

  • Nicole L. Garza

    (United States Army Medical Research Institute of Infectious Diseases)

  • Ginger Donnelly

    (United States Army Medical Research Institute of Infectious Diseases)

  • Amy C. Shurtleff

    (United States Army Medical Research Institute of Infectious Diseases)

  • Cary J. Retterer

    (United States Army Medical Research Institute of Infectious Diseases)

  • Dima Gharaibeh

    (United States Army Medical Research Institute of Infectious Diseases)

  • Rouzbeh Zamani

    (United States Army Medical Research Institute of Infectious Diseases)

  • Tara Kenny

    (United States Army Medical Research Institute of Infectious Diseases)

  • Brett P. Eaton

    (United States Army Medical Research Institute of Infectious Diseases)

  • Elizabeth Grimes

    (United States Army Medical Research Institute of Infectious Diseases)

  • Lisa S. Welch

    (United States Army Medical Research Institute of Infectious Diseases
    †Present addresses: LOKET Consulting, Clarksburg, Maryland 20871, USA (L.S.W.); Cocrystal Pharma, Tucker, Georgia 30084, USA (D.L.M).)

  • Laura Gomba

    (United States Army Medical Research Institute of Infectious Diseases
    United States Army Medical Research Institute of Infectious Diseases, Therapeutic Development Center)

  • Catherine L. Wilhelmsen

    (United States Army Medical Research Institute of Infectious Diseases)

  • Donald K. Nichols

    (United States Army Medical Research Institute of Infectious Diseases)

  • Jonathan E. Nuss

    (United States Army Medical Research Institute of Infectious Diseases
    United States Army Medical Research Institute of Infectious Diseases, Therapeutic Development Center)

  • Elyse R. Nagle

    (United States Army Medical Research Institute of Infectious Diseases)

  • Jeffrey R. Kugelman

    (United States Army Medical Research Institute of Infectious Diseases)

  • Gustavo Palacios

    (United States Army Medical Research Institute of Infectious Diseases)

  • Edward Doerffler

    (Gilead Sciences)

  • Sean Neville

    (Gilead Sciences)

  • Ernest Carra

    (Gilead Sciences)

  • Michael O. Clarke

    (Gilead Sciences)

  • Lijun Zhang

    (Gilead Sciences)

  • Willard Lew

    (Gilead Sciences)

  • Bruce Ross

    (Gilead Sciences)

  • Queenie Wang

    (Gilead Sciences)

  • Kwon Chun

    (Gilead Sciences)

  • Lydia Wolfe

    (Gilead Sciences)

  • Darius Babusis

    (Gilead Sciences)

  • Yeojin Park

    (Gilead Sciences)

  • Kirsten M. Stray

    (Gilead Sciences)

  • Iva Trancheva

    (Gilead Sciences)

  • Joy Y. Feng

    (Gilead Sciences)

  • Ona Barauskas

    (Gilead Sciences)

  • Yili Xu

    (Gilead Sciences)

  • Pamela Wong

    (Gilead Sciences)

  • Molly R. Braun

    (Boston University School of Medicine)

  • Mike Flint

    (Centers for Disease Control and Prevention)

  • Laura K. McMullan

    (Centers for Disease Control and Prevention)

  • Shan-Shan Chen

    (Gilead Sciences)

  • Rachel Fearns

    (Boston University School of Medicine)

  • Swami Swaminathan

    (Gilead Sciences)

  • Douglas L. Mayers

    (United States Army Medical Research Institute of Infectious Diseases
    †Present addresses: LOKET Consulting, Clarksburg, Maryland 20871, USA (L.S.W.); Cocrystal Pharma, Tucker, Georgia 30084, USA (D.L.M).)

  • Christina F. Spiropoulou

    (Centers for Disease Control and Prevention)

  • William A. Lee

    (Gilead Sciences)

  • Stuart T. Nichol

    (Centers for Disease Control and Prevention)

  • Tomas Cihlar

    (Gilead Sciences)

  • Sina Bavari

    (United States Army Medical Research Institute of Infectious Diseases
    United States Army Medical Research Institute of Infectious Diseases, Therapeutic Development Center)

Abstract

The discovery is reported of a small molecule drug, GS-5734, which has antiviral activity against Ebola virus and other filoviruses, and is capable of providing post-exposure therapeutic protection against lethal disease in 100% of drug-treated nonhuman primates infected with Ebola virus; the drug targets viral RNA polymerase and can distribute to sanctuary sites (such as testes, eyes and brain), suggesting that it may be able to clear persistent virus infection.

Suggested Citation

  • Travis K. Warren & Robert Jordan & Michael K. Lo & Adrian S. Ray & Richard L. Mackman & Veronica Soloveva & Dustin Siegel & Michel Perron & Roy Bannister & Hon C. Hui & Nate Larson & Robert Strickley , 2016. "Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys," Nature, Nature, vol. 531(7594), pages 381-385, March.
    • Handle: RePEc:nat:nature:v:531:y:2016:i:7594:d:10.1038_nature17180
    DOI: 10.1038/nature17180
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature17180
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature17180?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Farah Daou & Gretta Abou-Sleymane & Danielle A. Badro & Nagham Khanafer & Mansour Tobaiqy & Achraf Al Faraj, 2021. "The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19," IJERPH, MDPI, vol. 18(3), pages 1-16, January.
    2. Katja Voit & Cristian Timmermann & Florian Steger, 2021. "Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany—An Ethical Analysis," IJERPH, MDPI, vol. 18(11), pages 1-16, May.
    3. Jade Mitchell & Kara Dean & Charles Haas, 2020. "Ebola Virus Dose Response Model for Aerosolized Exposures: Insights from Primate Data," Risk Analysis, John Wiley & Sons, vol. 40(11), pages 2390-2398, November.
    4. Ropo E. Ogunsakin & Oluwakemi Ebenezer & Maryam A. Jordaan & Michael Shapi & Themba G. Ginindza, 2022. "Mapping Scientific Productivity Trends and Hotspots in Remdesivir Research Publications: A Bibliometric Study from 2016 to 2021," IJERPH, MDPI, vol. 19(14), pages 1-22, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:531:y:2016:i:7594:d:10.1038_nature17180. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.